Immunological contributions to adipose tissue homeostasis

Seminars in Immunology

Volumn 27, Issue 5, 2015, Pages 315-321

  DiSpirito, Joanna R ^a,b   Mathis, Diane ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adipocyte; Hyperplasia; Hypertrophy; Immunocyte; Obesity

Indexed keywords

ADIPOCYTOKINE; INSULIN; POLYUNSATURATED FATTY ACID;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; CELL FUNCTION; CELL INFILTRATION; DIET; FIBROSIS; HOMEOSTASIS; HUMAN; HYPERPLASIA; HYPERTROPHY; IMMUNOLOGY; INFLAMMATION; INTESTINE FLORA; LIPOLYSIS; LYMPHOCYTE; NONHUMAN; OVERNUTRITION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL COMMUNICATION; COMPLICATION; CYTOLOGY; ELASTICITY; ENERGY METABOLISM; IMMUNE SYSTEM; IMMUNITY; METABOLISM; OBESITY; PATHOLOGY;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; CELL COMMUNICATION; DIET; ELASTICITY; ENERGY METABOLISM; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY; INFLAMMATION; OBESITY; SIGNAL TRANSDUCTION;

EID: 84951763127     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2015.10.005     Document Type: Review

References (90)

1. Guilherme A., Virbasius J.V., Puri V., Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 2008, 9(5):367-377.
2. Nedergaard J., Cannon B. The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab. 2010, 11(4):268-272.
3. Xue B., Rim J.S., Hogan J.C., Coulter A.A., Koza R.A., Kozak L.P. Genetic variability affects the development of brown adipocytes in white fat but not in interscapular brown fat. J. Lipid Res. 2007, 48(1):41-51.
4. Vitali A., Murano I., Zingaretti M.C., Frontini A., Ricquier D., Cinti S. The adipose organ of obesity-prone C57BL/6J mice is composed of mixed white and brown adipocytes. J. Lipid Res. 2012, 53(4):619-629.
5. Wu J., Bostrom P., Sparks L.M., Ye L., Choi J.H., Giang A.H., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150(2):366-376.
6. Harms M., Seale P. Brown and beige fat: development, function and therapeutic potential. Nat. Med. 2013, 19(10):1252-1263.
7. Long J.Z., Svensson K.J., Tsai L., Zeng X., Roh H.C., Kong X., et al. A smooth muscle-like origin for beige adipocytes. Cell Metab. 2014, 19(5):810-820.
8. Tchkonia T., Thomou T., Zhu Y., Karagiannides I., Pothoulakis C., Jensen M.D., et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 2013, 17(5):644-656.
9. Rosen E.D., Spiegelman B.M. What we talk about when we talk about fat. Cell 2014, 156(1-2):20-44.
10. Smith U. Abdominal obesity: a marker of ectopic fat accumulation. J. Clin. Invest. 2015, 125(5):1790-1792.
11. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 2003, 112(12):1796-1808.
12. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 2003, 112(12):1821-1830.
13. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab. 2013, 17(6):851-859.
14. Odegaard J.I., Chawla A. Type 2 responses at the interface between immunity and fat metabolism. Curr. Opin. Immunol. 2015, 36:67-72.
15. Molofsky A.B., Nussbaum J.C., Liang H.E., Van Dyken S.J., Cheng L.E., Mohapatra A., et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 2013, 210(3):535-549.
16. Wu D., Molofsky A.B., Liang H.E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332(6026):243-247.
17. Liu J., Divoux A., Sun J., Zhang J., Clement K., Glickman J.N., et al. Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat. Med. 2009, 15(8):940-945.
18. Elgazar-Carmon V., Rudich A., Hadad N., Levy R. Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding. J. Lipid Res. 2008, 49(9):1894-1903.
19. Lumeng C.N., Bodzin J.L., Saltiel A.R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 2007, 117(1):175-184.
20. Zeyda M., Farmer D., Todoric J., Aszmann O., Speiser M., Gyori G., et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes. (Lond.) 2007, 31(9):1420-1428.
21. Xu X., Grijalva A., Skowronski A., van E.M., Serlie M.J., Ferrante A.W. Obesity activates a program of lysosomal-dependent lipid metabolism in adipose tissue macrophages independently of classic activation. Cell Metab. 2013, 18(6):816-830.
22. Kratz M., Coats B.R., Hisert K.B., Hagman D., Mutskov V., Peris E., et al. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab. 2014, 20(4):614-625.
23. Nishimura S., Manabe I., Takaki S., Nagasaki M., Otsu M., Yamashita H., et al. Adipose natural regulatory B cells negatively control adipose tissue inflammation. Cell Metab. 2013, 18:759-766.
24. Wu L., Parekh V.V., Hsiao J., Kitamura D., Van K.L. Spleen supports a pool of innate-like B cells in white adipose tissue that protects against obesity-associated insulin resistance. Proc. Natl. Acad. Sci. USA 2014, 111(43):E4638-E4647.
25. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 2009, 15(8):930-939.
26. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15(8):921-929.
27. Deiuliis J., Shah Z., Shah N., Needleman B., Mikami D., Narula V., et al. Visceral adipose inflammation in obesity is associated with critical alterations in T regulatory cell numbers. PLoS One 2011, 6(1):e16376.
28. Eller K., Kirsch A., Wolf A.M., Sopper S., Tagwerker A., Stanzl U., et al. Potential role of regulatory T cells in reversing obesity-linked insulin resistance and diabetic nephropathy. Diabetes 2011, 60(11):2954-2962.
29. Cipolletta D., Feuerer M., Li A., Kamei N., Lee J., Shoelson S.E., et al. PPAR-gamma is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012, 486(7404):549-553.
30. Lynch L., Michelet X., Zhang S., Brennan P.J., Moseman A., Lester C., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 2015, 16(1):85-95.
31. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 2008, 103(5):467-476.
32. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15(8):914-920.
33. Winer D.A., Winer S., Shen L., Wadia P.P., Yantha J., Paltser G., et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 2011, 17(5):610-617.
34. DeFuria J., Belkina A.C., Jagannathan-Bogdan M., Snyder-Cappione J., Carr J.D., Nersesova Y.R., et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl. Acad. Sci. USA 2013, 110(13):5133-5138.
35. Czech M.P., Tencerova M., Pedersen D.J., Aouadi M. Insulin signalling mechanisms for triacylglycerol storage. Diabetologia 2013, 56(5):949-964.
36. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389(6651):610-614.
37. Xu H., Hirosumi J., Uysal K.T., Guler A.D., Hotamisligil G.S. Exclusive action of transmembrane TNF alpha in adipose tissue leads to reduced adipose mass and local but not systemic insulin resistance. Endocrinology 2002, 143(4):1502-1511.
38. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259(5091):87-91.
39. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu. Rev. Immunol. 2011, 29:415-445.
40. Duffaut C., Zakaroff-Girard A., Bourlier V., Decaunes P., Maumus M., Chiotasso P., et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol. 2009, 29(10):1608-1614.
41. McGillicuddy F.C., Chiquoine E.H., Hinkle C.C., Kim R.J., Shah R., Roche H.M., et al. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 2009, 284(46):31936-31944.
42. Furuhashi M., Fucho R., Gorgun C.Z., Tuncman G., Cao H., Hotamisligil G.S. Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J. Clin. Invest. 2008, 118(7):2640-2650.
43. Zuniga L.A., Shen W.J., Joyce-Shaikh B., Pyatnova E.A., Richards A.G., Thom C., et al. IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J. Immunol. 2010, 185(11):6947-6959.
44. Lee M.W., Odegaard J.I., Mukundan L., Qiu Y., Molofsky A.B., Nussbaum J.C., et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2015, 160(1-2):74-87.
45. Brestoff J.R., Kim B.S., Saenz S.A., Stine R.R., Monticelli L.A., Sonnenberg G.F., et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2015, 519(7542):242-246.
46. Grant R.W., Stephens J.M. Fat in flames: influence of cytokines and pattern recognition receptors on adipocyte lipolysis. Am. J. Physiol. Endocrinol. Metab. 2015, 309(3):E205-E213.
47. Tsao C.H., Shiau M.Y., Chuang P.H., Chang Y.H., Hwang J. Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis. J. Lipid. Res. 2014, 55(3):385-397.
48. Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 2011, 186(6):3299-3303.
49. Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., et al. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006, 4(1):13-24.
50. Fasshauer M., Bluher M. Adipokines in health and disease. Trends Pharmacol. Sci. 2015, 36(7):461-470.
51. Friedman J. 20 years of leptin: leptin at 20: an overview. J. Endocrinol. 2014, 223(1):T1-T8.
52. Loffreda S., Yang S.Q., Lin H.Z., Karp C.L., Brengman M.L., Wang D.J., et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998, 12(1):57-65.
53. Lord G.M., Matarese G., Howard J.K., Baker R.J., Bloom S.R., Lechler R.I. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998, 394(6696):897-901.
54. Santos-Alvarez J., Goberna R., Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999, 194(1):6-11.
55. Schwartz D.R., Lazar M.A. Human resistin: found in translation from mouse to man. Trends Endocrinol. Metab. 2011, 22(7):259-265.
56. Bokarewa M., Nagaev I., Dahlberg L., Smith U., Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J. Immunol. 2005, 174(9):5789-5795.
57. Kaser S., Kaser A., Sandhofer A., Ebenbichler C.F., Tilg H., Patsch J.R. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 2003, 309(2):286-290.
58. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11(2):85-97.
59. Maeda N., Shimomura I., Kishida K., Nishizawa H., Matsuda M., Nagaretani H., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat. Med. 2002, 8(7):731-737.
60. Yamaguchi N., Argueta J.G., Masuhiro Y., Kagishita M., Nonaka K., Saito T., et al. Adiponectin inhibits Toll-like receptor family-induced signaling. FEBS Lett. 2005, 579(30):6821-6826.
61. Kumada M., Kihara S., Ouchi N., Kobayashi H., Okamoto Y., Ohashi K., et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004, 109(17):2046-2049.
62. Berg A.H., Scherer P.E. Adipose tissue, inflammation, and cardiovascular disease. Circ. Res. 2005, 96(9):939-949.
63. Divoux A., Tordjman J., Lacasa D., Veyrie N., Hugol D., Aissat A., et al. Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 2010, 59(11):2817-2825.
64. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. J. Clin. Invest. 2011, 121(6):2094-2101.
65. Vila I.K., Badin P.M., Marques M.A., Monbrun L., Lefort C., Mir L., et al. Immune cell Toll-like receptor 4 mediates the development of obesity- and endotoxemia-associated adipose tissue fibrosis. Cell Rep. 2014, 7(4):1116-1129.
66. Divoux A., Moutel S., Poitou C., Lacasa D., Veyrie N., Aissat A., et al. Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J. Clin. Endocrinol. Metab. 2012, 97(9):E1677-E1685.
67. Wang Q.A., Tao C., Gupta R.K., Scherer P.E. Tracking adipogenesis during white adipose tissue development, expansion and regeneration. Nat. Med. 2013, 19(10):1338-1344.
68. Kim S.M., Lun M., Wang M., Senyo S.E., Guillermier C., Patwari P., et al. Loss of white adipose hyperplastic potential is associated with enhanced susceptibility to insulin resistance. Cell Metab. 2014, 20(6):1049-1058.
69. Strissel K.J., Stancheva Z., MIYOSHI H., Perfield J.W., DeFuria J., Jick Z., et al. Adipocyte death, adipose tissue remodeling, and obesity complications. Diabetes 2007, 56(12):2910-2918.
70. Lee Y.H., Petkova A.P., Granneman J.G. Identification of an adipogenic niche for adipose tissue remodeling and restoration. Cell Metab. 2013, 18(3):355-367.
71. Kosteli A., Sugaru E., Haemmerle G., Martin J.F., Lei J., Zechner R., et al. Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue. J. Clin. Invest. 2010, 120(10):3466-3479.
72. Mottillo E.P., Shen X.J., Granneman J.G. Role of hormone-sensitive lipase in beta-adrenergic remodeling of white adipose tissue. Am. J. Physiol. Endocrinol. Metab. 2007, 293(5):E1188-E1197.
73. Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3(4):213-223.
74. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 2006, 116(11):3015-3025.
75. Davis J.E., Gabler N.K., Walker-Daniels J., Spurlock M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity (Silver Spring) 2008, 16(6):1248-1255.
76. Erridge C., Samani N.J. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler. Thromb. Vasc. Biol. 2009, 29(11):1944-1949.
77. Jin C., Flavell R.A. Innate sensors of pathogen and stress: linking inflammation to obesity. J. Allergy Clin. Immunol. 2013, 132(2):287-294.
78. Ruzickova J., Rossmeisl M., Prazak T., Flachs P., Sponarova J., Veck M., et al. Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 2004, 39(12):1177-1185.
79. Siriwardhana N., Kalupahana N.S., Cekanova M., Lemieux M., Greer B., Moustaid-Moussa N. Modulation of adipose tissue inflammation by bioactive food compounds. J. Nutr. Biochem. 2013, 24(4):613-623.
80. Kalupahana N.S., Claycombe K., Newman S.J., Stewart T., Siriwardhana N., Matthan N., et al. Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J. Nutr. 2010, 140(11):1915-1922.
81. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142(5):687-698.
82. Ichimura A., Hirasawa A., Poulain-Godefroy O., Bonnefond A., Hara T., Yengo L., et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012, 483(7389):350-354.
83. Monk J.M., Liddle D.M., De Boer A.A., Brown M.J., Power K.A., Ma D.W., et al. Fish-oil-derived n-3 PUFAs reduce inflammatory and chemotactic adipokine-mediated cross-talk between co-cultured murine splenic CD8+ T cells and adipocytes. J. Nutr. 2015, 145(4):829-838.
84. Khan M.T., Nieuwdorp M., Backhed F. Microbial modulation of insulin sensitivity. Cell Metab. 2014, 20(5):753-760.
85. Rosenbaum M., Knight R., Leibel R.L. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol. Metab. 2015, 26(9):493-501.
86. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457(7228):480-484.
87. Amar J., Serino M., Lange C., Chabo C., Iacovoni J., Mondot S., et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011, 54(12):3055-3061.
88. Amar J., Chabo C., Waget A., Klopp P., Vachoux C., Bermudez-Humaran L.G., et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 2011, 3(9):559-572.
89. Caesar R., Reigstad C.S., Backhed H.K., Reinhardt C., Ketonen M., Lunden G.O., et al. Gut-derived lipopolysaccharide augments adipose macrophage accumulation but is not essential for impaired glucose or insulin tolerance in mice. Gut 2012, 61(12):1701-1707.
90. Caesar R., Tremaroli V., Kovatcheva-Datchary P., Cani P.D., Backhed F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab. 2015, 22(4):658-668.